Medical Design Technology -
13 Feb 2017 18:37
News This is the first time that an Osmium-based compound - which is fifty times more active than the current cancer drug cisplatin - has been seen to target the disease ... Contributed Author: University of Warwick Topics: STEM
Share this Article